Clinical use of Bevacizumab in treating refractory glaucoma

about

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy

P2860

Q28067341-B6C218B0-9375-4116-9294-C9E7F564293A

P2860

Clinical use of Bevacizumab in treating refractory glaucoma

Item

http://www.wikidata.org/entity/Q28083405

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Clinical use of Bevacizumab in treating refractory glaucoma

@ast

Clinical use of Bevacizumab in treating refractory glaucoma

@en

Clinical use of Bevacizumab in treating refractory glaucoma

@nl

type

Item

label

Clinical use of Bevacizumab in treating refractory glaucoma

@ast

Clinical use of Bevacizumab in treating refractory glaucoma

@en

Clinical use of Bevacizumab in treating refractory glaucoma

@nl

prefLabel

Clinical use of Bevacizumab in treating refractory glaucoma

@ast

Clinical use of Bevacizumab in treating refractory glaucoma

@en

Clinical use of Bevacizumab in treating refractory glaucoma

@nl

P1476

Clinical use of Bevacizumab in treating refractory glaucoma

@en

P2093

Alexandrescu C

http://www.w3.org/2001/XMLSchema#string

Iancu R

http://www.w3.org/2001/XMLSchema#string

Popescu V

http://www.w3.org/2001/XMLSchema#string

Pricopie S

http://www.w3.org/2001/XMLSchema#string

Totir M

http://www.w3.org/2001/XMLSchema#string

Yasyn S

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Tumor angiogenesis: therapeutic implications

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.

FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.

Corneal Melt While Using Topical Bevacizumab Eye Drops.

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

P304

8-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P3181

2804343

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25914729

http://www.w3.org/2001/XMLSchema#string

P921

P932

4397528

http://www.w3.org/2001/XMLSchema#string

Clinical use of Bevacizumab in treating refractory glaucoma

about

P2860

P2860

Clinical use of Bevacizumab in treating refractory glaucoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P3181

P407

P433

P478

P5008

P577

P698

P921

P932

P3181

P1433

P1476

P2093

P275

P2860

P304

P31

P3181

P407

P433

P478

P5008

P577

P698

P921

P932